All Products

Cat.No.

Product Name / Activity

Potent cathepsin K inhibitor

High affinity NK₁ receptor antagonist

Potent and selective sst₂ agonist

Potent, selective non-peptide NPY Y₅ receptor antagonist

Selective EP₄ receptor antagonist

Potent PPARδ agonist

Potent, orally active human glucagon receptor antagonist

DNA ligase I, III and IV inhibitor

K_V7.1 channel activator, activates I_Ks

Selective CCK₂ antagonist

Potent, non-peptide oxytocin receptor antagonist

Potent and selective oxytocin receptor antagonist

Ca²⁺ channel blocker

Potent, selective thromboxane A₂/prostaglandin endoperoxide antagonist

Selective for α5-containing GABA_A receptors

Potent, selective thromboxane A₂/prostaglandin endoperoxide antagonist

Potent and selective γ-secretase inhibitor

Very potent NMDA antagonist

Cell permeable prodrug of the IMPase inhibitor L-690,330 (Cat. No. 0681)

Inositol monophosphatase inhibitor

Potent, non-peptide ghrelin receptor agonist

High affinity σ ligand

5-HT_1D agonist

NMDA antagonist, acts glycine site

NMDA antagonist, acts at glycine site

Selective 5-HT_1D receptor agonist

Potent, selective NK₁ antagonist

Potent NK₁ antagonist

Highly selective D₄ antagonist

High affinity D₂ antagonist

Highly selective D₄ antagonist

Selective β₃ antagonist

Very potent and selective β₃ partial agonist

Highly selective CB₂ agonist

High affinity, selective CB₂ agonist

Potent Raf kinase inhibitor

Potent and highly selective EP₃ antagonist

Substrate-competitive inhibitor of GSK-3

Potent and selective sst₄ agonist

Selective inhibitor of GSK-3

Potent and selective sst₅ agonist

Subtype-selective GABA_A partial agonist

Cell-permeable, potent and selective proteasome inhibitor

Inhibits glutamate release. Anticonvulsant

Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611)

H⁺,K⁺-ATPase inhibitor

DNA topoisomerase I inhibitor

FP prostaglandin receptor agonist; also exhibits agonist activity at EP₁ and EP₃ receptors

Inhibitor of actin assembly and polymerization

Intermediate in lipid metabolism

Analog of LF 11 (Cat. No. 4421); antibiotic

EGFR, p60^c-src inhibitor

Selective MAO-B inhibitor

Selective farnesyltransferase (FTase) inhibitor

Transglutaminase 2 (TG2) inhibitor; reversible

Ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitor

Dopamine precursor

Fluorescent ligand for α₄β₁ (VLA-4)

Selective RARβ antagonist

Potent and selective dopamine D₁ antagonist

CB₁ agonist

Dihydroorotate dehydrogenase inhibitor

Fluorogenic caspase substrate

Synthetic leptin peptide fragment

Inhibits nuclear export of proteins; antitumor

Ca²⁺ channel blocker (L-type)

JAK2, FLT3 and TrkA inhibitor

Potent, reversible non-steroidal aromatase inhibitor

BLT₁/BLT₂ receptor agonist and potent chemotactic factor

Inhibits trypsin-like/cysteine proteases

GnRH receptor agonist

K_ir6 (K_ATP) channel opener. Active enantiomer of cromakalim (Cat. No. 1377)

Antiepileptic; binds SV2A

Synthetic progesterone analog

Antibiotic; neutralizes LPS

Potent, selective BTK inhibitor

RXR:PPAR agonist

Selective RXR modulator

Blocks retinoic acid metabolism

Active metabolite of oxcarbazepine (Cat. No. 3684)

Na⁺ channel blocker

Antibiotic; inhibits protein synthesis in gram-positive bacteria

Immunomodulator with antiangiogenic properties

K_V7 (KCNQ) channel blocker

Selective ERβ agonist

DA receptor agonist; antiparkinson's agent.

Mood stabilizer; inhibits Na⁺/K⁺ ATPase pump activity

Amphibian bombesin-like peptide

Potent TrkB agonist

Nicotinic agonist

Insect tachykinin-related peptide (TRP)

Broad spectrum cation channel blocker; neuroprotective

5-HT and noradrenalin re-uptake inhibitor (SNRI)

MGMT inhibitor

Mitochondrial hexokinase inhibitor

Peripherally acting μ agonist. Also Ca²⁺ channel blocker

Peripheral H₁ antagonist; antiallergic agent

Acts at the benzodiazepine modulatory site

Subtype-selective GABA_A receptor modulator

Selective, non-peptide AT₁ antagonist

HMG-CoA reductase inhibitor

5-HT₇ agonist

Selective 5-HT₇ ligand

High affinity 5-HT₇ agonist

Binds Aβ; protects from aggregation induced toxicity

Control peptide for SLIGRL-NH₂ (Cat. No. 1468)

Potent and selective LRRK2 inhibitor

Potent NPY Y₅ receptor antagonist

Anti-inflammatory, antioxidant and free radical scavenger

Competitive melatonin MT₁/MT₂ antagonist

Selective, orally active LTD₄ antagonist

Potentiator of α7 nAChRs

5-HT₂/5-HT₇ antagonist

Novel, potent anandamide uptake inhibitor. Inhibits FAAH

Potent CCK₂ antagonist

Competitive NMDA receptor antagonist

Competitive NMDA antagonist

Potent and selective GlyT1 inhibitor

Selective, competitive BLT₂ receptor antagonist

Selective 5-HT_2B receptor antagonist

High affinity 5-HT_2B antagonist, orally active

Selective CCK₂ antagonist

Selective PI 3-kinase inhibitor

Negative control of LY 294002 (Cat. No. 1130)

5-HT_1D-preferring antagonist

Selective secreted phospholipase A₂ (sPLA₂) inhibitor

Selective CB₁ receptor antagonist/inverse agonist

Protein kinase C inhibitor; selective for β isozymes

Selective 5-HT_1F agonist

Highly potent, selective group II antagonist

Disodium salt of LY 341495 (Cat. No. 1209)

Potent, selective 5-HT_1F agonist

Potent and highly selective group II mGlu agonist

Selective inhibitor of TGF-βRI

Selective mGlu_1a antagonist

Highly selective group II mGlu agonist

Dual 5-HT_1B/1D antagonist and 5-HT re-uptake inhibitor

Mixed mGlu₂ agonist/ mGlu₃ antagonist

Selective mGlu₁ antagonist

Positive allosteric modulator selective for mGlu₂

Phenylethanolamine-N-methyltransferase inhibitor

Inhibits Lyn-dependent activities of IL-5 receptor; cell-permeable

Pro-opiomelanocortin (POMC) derived peptide